BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35128664)

  • 1. Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center.
    Nassif EF; Cope B; Traweek R; Witt RG; Erstad DJ; Scally CP; Thirasastr P; Zarzour MA; Ludwig J; Benjamin R; Bishop AJ; Guadagnolo BA; Ingram D; Wani K; Wang WL; Lazar AJ; Torres KE; Hunt KK; Feig BW; Roland CL; Somaiah N; Keung EZ
    Int J Cancer; 2022 Jun; 150(12):2012-2024. PubMed ID: 35128664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
    Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
    J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma.
    Thirasastr P; Lin H; Amini B; Wang WL; Cloutier JM; Nassif EF; Keung EZ; Roland CL; Feig B; Araujo D; Benjamin RS; Conley AP; Livingston JA; Ludwig J; Patel S; Ratan R; Ravi V; Zarzour MA; Zhou X; Somaiah N
    Cancer Med; 2023 Feb; 12(4):4282-4293. PubMed ID: 36151848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.
    Haas RLM; Bonvalot S; Miceli R; Strauss DC; Swallow CJ; Hohenberger P; van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Gladdy R; Jakob J; Szacht M; Fiore M; Chung PW; van Houdt WJ; Raut CP; Gronchi A
    Cancer; 2019 Apr; 125(8):1290-1300. PubMed ID: 30602058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit.
    Ikoma N; Roland CL; Torres KE; Chiang YJ; Wang WL; Somaiah N; Mann GN; Hunt KK; Cormier JN; Feig BW
    Ann Surg Oncol; 2018 Aug; 25(8):2193-2200. PubMed ID: 29520652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the preadipocyte marker ZFP423 is dysregulated between well-differentiated and dedifferentiated liposarcoma.
    Dang TN; Tiongco RP; Brown LM; Taylor JL; Lyons JM; Lau FH; Floyd ZE
    BMC Cancer; 2022 Mar; 22(1):300. PubMed ID: 35313831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Palbociclib May be Associated with Delayed Recurrence in Completely Resected Retroperitoneal Liposarcoma: Results of a Single-Institution Retrospective Cohort Study.
    Selby LV; Clark EC; Liebner DA; Chen JL; Tinoco G; Bashian E; Beane JD; Pollock RE; Grignol VP
    Ann Surg Oncol; 2023 Nov; 30(12):7876-7881. PubMed ID: 37330448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
    Creytens D; Van Gorp J; Speel EJ; Ferdinande L
    Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of dedifferentiated liposarcoma in the extremities: A retrospective case series of 7 patients.
    Kito M; Yoshimura Y; Isobe K; Aoki K; Suzuki S; Tanaka A; Okamoto M; Sano K; Kato H
    J Orthop Sci; 2016 Sep; 21(5):673-7. PubMed ID: 27317086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Well-differentiated liposarcomas and dedifferentiated liposarcomas: Systemic treatment options for two sibling neoplasms.
    Kyriazoglou A; Pagkali A; Kotsantis I; Economopoulou P; Kyrkasiadou M; Moutafi M; Gavrielatou N; Anastasiou M; Boulouta A; Pantazopoulos A; Giannakakou M; Digklia A; Psyrri A
    Cancer Treat Rev; 2024 Apr; 125():102716. PubMed ID: 38492514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas.
    Laroche-Clary A; Chaire V; Algeo MP; Derieppe MA; Loarer FL; Italiano A
    J Hematol Oncol; 2017 Jun; 10(1):123. PubMed ID: 28629371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of
    Rekhi B; Karnik N; Agrawal R; Shetty O; Patkar S
    Indian J Pathol Microbiol; 2022; 65(1):65-75. PubMed ID: 35074968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors.
    Peng T; Zhang P; Liu J; Nguyen T; Bolshakov S; Belousov R; Young ED; Wang X; Brewer K; López-Terrada DH; Oliveira AM; Lazar AJ; Lev D
    Lab Invest; 2011 Mar; 91(3):392-403. PubMed ID: 21060307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma.
    Lu J; Wood D; Ingley E; Koks S; Wong D
    Mol Biol Rep; 2021 Apr; 48(4):3637-3647. PubMed ID: 33893924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin.
    Fabbroni C; Fucà G; Ligorio F; Fumagalli E; Barisella M; Collini P; Morosi C; Gronchi A; Dei Tos AP; Casali PG; Sanfilippo R
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33810165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial.
    Dickson MA; Schwartz GK; Keohan ML; D'Angelo SP; Gounder MM; Chi P; Antonescu CR; Landa J; Qin LX; Crago AM; Singer S; Koff A; Tap WD
    JAMA Oncol; 2016 Jul; 2(7):937-40. PubMed ID: 27124835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Histologic Subtype and FNCLCC Grade by SUVmax Measured on
    Li CP; Liu DN; Zhou NN; Tian XY; Wang Z; Liu BN; Hao CY
    Contrast Media Mol Imaging; 2021; 2021():7191363. PubMed ID: 33505228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma.
    He M; Aisner S; Benevenia J; Patterson F; Harrison LE; Hameed M
    Pathol Res Pract; 2009; 205(6):386-94. PubMed ID: 19186005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical behavior of well differentiated liposarcoma can be extremely variable: A retrospective cohort study at a major sarcoma center.
    Keung EZ; Ikoma N; Benjamin R; Wang WL; Lazar AJ; Feig BW
    J Surg Oncol; 2018 Jun; 117(8):1799-1805. PubMed ID: 29723411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).
    Nessim C; Raut CP; Callegaro D; Barretta F; Miceli R; Fairweather M; Blay JY; Strauss D; Rutkowski P; Ahuja N; Gonzalez R; Grignani G; Quagliuolo V; Stoeckle E; Lahat G; De Paoli A; Pillarisetty VG; Canter RJ; Mullen JT; Pennacchioli E; van Houdt W; Swallow CJ; Schrage Y; Cardona K; Fiore M; Gronchi A; Bagaria SP
    Ann Surg Oncol; 2021 Nov; 28(12):7854-7863. PubMed ID: 33907921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.